A Phase II Prospective Blinded Trial of Magnetic Resonance Imaging and In-Bore Biopsy in Active Surveillance for Prostate Cancer
BJ Langbein, B Berk, C Bay, K Tuncali, N Martin… - Urology, 2024 - Elsevier
Objective To demonstrate the added benefit of multiparametric (mp) MRI risk stratification
during active surveillance. Methods This prospective, single-arm, nonrandomized study …
during active surveillance. Methods This prospective, single-arm, nonrandomized study …
A Phase II Prospective Blinded Trial of Magnetic Resonance Imaging and In-Bore Biopsy in Active Surveillance for Prostate Cancer
BJ Langbein, B Berk, C Bay, K Tuncali, N Martin… - Urology, 2024 - goldjournal.net
Objective To demonstrate the added benefit of multiparametric (mp) MRI risk stratification
during active surveillance. Methods This prospective, single-arm, nonrandomized study …
during active surveillance. Methods This prospective, single-arm, nonrandomized study …
A Phase II Prospective Blinded Trial of Magnetic Resonance Imaging and In-Bore Biopsy in Active Surveillance for Prostate Cancer
BJ Langbein, B Berk, C Bay, K Tuncali, N Martin… - …, 2024 - pubmed.ncbi.nlm.nih.gov
Objective To demonstrate the added benefit of multiparametric (mp) MRI risk stratification
during active surveillance. Methods This prospective, single-arm, nonrandomized study …
during active surveillance. Methods This prospective, single-arm, nonrandomized study …
[HTML][HTML] A Phase II Prospective Blinded Trial of MRI and In-Bore Biopsy in Active Surveillance for Prostate Cancer
BJ Langbein, B Berk, C Bay, K Tuncali, N Martin… - Urology, 2024 - ncbi.nlm.nih.gov
Objective: To demonstrate the added benefit of multiparametric (mp) MRI risk stratification
during active surveillance. Methods: This prospective, single-arm, non-randomized study …
during active surveillance. Methods: This prospective, single-arm, non-randomized study …